S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
66,000% upside on tiny biotech? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
66,000% upside on tiny biotech? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
66,000% upside on tiny biotech? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
66,000% upside on tiny biotech? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Hollywood's writers strike is on the verge of ending. What happens next?
NYSE:CO

Global Cord Blood (CO) Stock Forecast, Price & News

$1.23
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$1.23
$1.23
50-Day Range
$0.90
$1.84
52-Week Range
$2.03
$5.50
Volume
118 shs
Average Volume
216,519 shs
Market Capitalization
$149.51 million
P/E Ratio
1.92
Dividend Yield
N/A
Price Target
N/A

CO stock logo

About Global Cord Blood (NYSE:CO) Stock

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.

CO Price History

CO Stock News Headlines

ONWARD® Reports 2023 Half Year Results and Business Update
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
StockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Global Cord Blood Corp Shs Stock Settlement
MAK-System partners with New York Blood Centre Enterprises
See More Headlines
Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Company Calendar

Last Earnings
6/26/2018
Today
9/24/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
1,202
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$0.29 per share
Book Value
$6.34 per share

Miscellaneous

Free Float
N/A
Market Cap
$149.51 million
Optionable
Optionable
Beta
0.16
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Ting Zheng
    Chairman & Chief Executive Officer
  • Bing Chuen Chen
    Chief Financial Officer & Director
  • Xin Xu
    Chief Technology Officer
  • Rui Arashiyama
    CEO-Guangdong & Zhejiang Divisions













CO Stock - Frequently Asked Questions

How have CO shares performed in 2023?

Global Cord Blood's stock was trading at $2.9876 on January 1st, 2023. Since then, CO stock has decreased by 58.8% and is now trading at $1.23.
View the best growth stocks for 2023 here
.

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) released its quarterly earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter.

Is Global Cord Blood a good dividend stock?

Global Cord Blood (NYSE:CO) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CO.

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL).

What is Global Cord Blood's stock symbol?

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

How do I buy shares of Global Cord Blood?

Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $1.23.

How much money does Global Cord Blood make?

Global Cord Blood (NYSE:CO) has a market capitalization of $149.51 million and generates $1.24 billion in revenue each year. The medical research company earns $79.04 million in net income (profit) each year or $0.64 on an earnings per share basis.

How many employees does Global Cord Blood have?

The company employs 1,202 workers across the globe.

How can I contact Global Cord Blood?

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The official website for the company is www.globalcordbloodcorp.com. The medical research company can be reached via phone at (523) 605-8180, via email at ir@globalcordbloodcorp.com, or via fax at 852-3605-8181.

This page (NYSE:CO) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -